HSPG2 and cancer: Overexpression of Trefoil factor 1 is involved in pathways, including Rho-GTPases, Rho-kinase, PI3-kinase, PLC, and COX-2 and they interact with other receptor systems to activate epidermal growth factor receptor EGFR indirectly causing progression of cancer (73).